The Use of Lymphocyte Function–Associated Antigen (Lfa)-1–Deficient Mice to Determine the Role of Lfa-1, Mac-1, and α4 Integrin in the Inflammatory Response of Neutrophils

por Henderson, Robert B., Lim, Lina H.K., Tessier, Philippe A., Gavins, Felicity N.E., Mathies, Meg, Perretti, Mauro, Hogg, Nancy
Publicado 2001

A novel Rac-dependent checkpoint in B cell development controls entry into the splenic white pulp and cell survival

por Henderson, Robert B., Grys, Katarzyna, Vehlow, Anne, de Bettignies, Carine, Zachacz, Agnieszka, Henley, Tom, Turner, Martin, Batista, Facundo, Tybulewicz, Victor L.J.
Publicado 2010

Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy

por Barrett, Christine, Willcocks, Lisa C, Jones, Rachel B, Tarzi, Ruth M, Henderson, Robert B, Cai, Gengqian, Gisbert, Sophie I, Belson, Alexandra S, Savage, Caroline O
Publicado 2020

The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysis

por Wilkinson, Christel, Henderson, Robert B., Jones-Leone, Angela R., Flint, Shaun M., Lennon, Mark, Levy, Roger A., Ji, Beulah, Bass, Damon L., Roth, David
Publicado 2020

Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lu...

por Teng, Y K Onno, Bruce, Ian N, Diamond, Betty, Furie, Richard A, van Vollenhoven, Ronald F, Gordon, David, Groark, James, Henderson, Robert B, Oldham, Mary, Tak, Paul P
Publicado 2019

A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol

por McClure, Mark E., Gopaluni, Seerapani, Wason, James, Henderson, Robert B., Van Maurik, Andre, Savage, Caroline C.O., Pusey, Charles D., Salama, Alan D., Lyons, Paul A., Lee, Jacinta, Mynard, Kim, Jayne, David R., Jones, Rachel B.
Publicado 2023

Identifying cell-enriched miRNAs in kidney injury and repair

por Connor, Katie L., Teenan, Oliver, Cairns, Carolynn, Banwell, Victoria, Thomas, Rachel A.B., Rodor, Julie, Finnie, Sarah, Pius, Riinu, Tannahill, Gillian M., Sahni, Vishal, Savage, Caroline O.S., Hughes, Jeremy, Harrison, Ewen M., Henderson, Robert B., Marson, Lorna P., Conway, Bryan R., Wigmore, Stephen J., Denby, Laura
Publicado 2020

A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren’s syndrome

por Mariette, Xavier, Barone, Francesca, Baldini, Chiara, Bootsma, Hendrika, Clark, Kenneth L., De Vita, Salvatore, Gardner, David H., Henderson, Robert B., Herdman, Michael, Lerang, Karoline, Mistry, Prafull, Punwaney, Raj, Seror, Raphaele, Stone, John, van Daele, Paul L.A., van Maurik, André, Wisniacki, Nicolas, Roth, David A., Tak, Paul Peter
Publicado 2022

Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Randomized Controlled Study

por Jayne, David, Blockmans, Daniel, Luqmani, Raashid, Moiseev, Sergey, Ji, Beulah, Green, Yulia, Hall, Leanne, Roth, David, Henderson, Robert B., Merkel, Peter A., Lozano, Jose Alfaro, Becker, Heidemarie, Quiroz, Armando Calvo, Carette, Simon, Carrillo‐Vazquez, Sandra, Cid, María C., D'Cruz, David, Deodhar, Atul, Flossman, Oliver, Garibotto, Giacomo, Gesualdo, Loreto, Hall, Stephen, Hauser, Thomas, Hellmich, Bernhard, Kidder, Dana, Kimmel, Martin, Little, Mark, Majdan, Maria, Maksimowicz‐McKinnon, Kathleen, Marder, Galina, Matsievskaia, Galina, Meneses, Ariel Salinas, Molloy, Eamonn, Mueller, Ruediger, Neuwelt, Clark, Hernandez, Jorge Ravelo, Specks, Ulrich, Tesar, Vladimir, Walsh, Michael
Publicado 2019